Evaluation of the relationships between beta-human chorionic gonadotropin (β-hCG) blood levels and pregnancy: A retrospective study.

Objective: To retrospectively evaluate the relationships between beta-human chorionic gonadotropin (β-hCG) blood levels and pregnancy in primary care. Methods: The retrospective study was conducted in Bursa Uludağ University Family Health Center in Turkey between October 1 Results: The mean age of the 239 pregnant women who participated in the study was 28.74±4.02, and the mean total gestational age was 37.28±7.68 weeks. It was determined that 96.2% of the pregnant women had total β-hCG levels in the blood above 5 mIU/ml. Risk factors were present in 26.4% of the pregnant women, and 3.8% of them developed complications during pregnancy. Blood β-hCG levels were higher in those who had an additional disease during pregnancy, those who were on medication, those who had risk factors, and those who developed complications. While total β-hCG measurement levels were lower in those who had normal or cesarean live births, they were higher in those who had abortions (p=0.03). Conclusion: In our study, blood β-hCG levels were higher in pregnant women who had an additional disease, those who were on medication, those who had risk factors and those who developed complications. Total β-hCG measurement levels were lower in those who had normal or cesarean live births, while they were higher in those who had abortions. Different results in blood β-hCG levels require a holistic approach to evaluate pregnancy. In this critical process, the collaboration of family physicians with obstetrics, gynecology and other clinics is important.